SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
OCATA THERAPEUTICS
An SI Board Since November 2010
Posts SubjectMarks Bans Symbol
134 5 0 OCAT
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
Advanced Cell Technology, Inc. is NOW OCATA symbol OCAT biotechnology company applying cellular technology in the field of regenerative medicine.

For more information, visit ocata.com.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
134How interesting that OCAT nudged up for a week, and then sold off yesterday...riSavant-11/10/2015
133'I See' OCAT sold out...$8.50 up 88%... - New Step Forward in OphSavant-11/10/2015
132$OCAT closed up 9.19 percent on Monday, August 24, 2015, on 2.76 times normal vomore10018/25/2015
131New Patent Strengthens Ocata’s Proprietary Position of its RPE Manufacturing ProSavant-8/19/2015
130 Ocata Therapeutics Receives Three New U.S. Patents for its RPE TheraSavant-5/26/2015
129June 1st Ocata Therapeutics to Present at the Jefferies 2015 GlobSavant-5/18/2015
128Current CC/Webcast available/ Ocata Therapeutics to Host Conference CallSavant-5/11/2015
127 Dr Robert Lanza, Chief Scientific Officer of Ocata Therapeutics to bSavant-5/11/2015
126 Ocata Therapeutics Announces Positive Results in Treating Macular Savant14/30/2015
125Transitioning to induced cells should deflect resistance/criticism against usingSavant-3/24/2015
124 Ocata Therapeutics Licenses Induced Pluripotent Stem Cell TechnologySavant-3/24/2015
123 Ocata Therapeutics Receives Regulatory Guidance from European MediciSavant-3/17/2015
122Ocata Therapeutics to Host Conference Call and Webcast to Provide CorporaSavant-3/12/2015
121 Ocata Therapeutics Approved for Listing on NASDAQTrading under Savant-2/26/2015
120Ocata Therapeutics Receives Two New Patents for Immune-modulatory Cell TechnologSavant-2/25/2015
119RT... Second Sight Announces First Commercial Implants of the Argus(R) II RetinaSavant-2/24/2015
118 Advanced Cell Technology Changes Name to Ocata TherapeuticsNew Name Savant-11/14/2014
117ACT Reports the Publication of Research on the Scalable Generation of Universal Savant-10/17/2014
116npr.orgSavant-10/15/2014
115Stem Cells Seem Safe in Treating Eye Disease A treatment based on embryonic stFJB-10/15/2014
114Advanced Cell Technology Announces Issuance of Patent Covering Dendritic Cells MSavant-9/5/2014
113Distinguished Scientists Join Advanced Cell Technology's New Scientific AdviSavant-9/3/2014
112[Text Chart] Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a lSavant-8/27/2014
111Advanced Cell Technology to Host Conference Call to Provide a Corporate Update Savant18/7/2014
110Advanced Cell Technology Secures $30 Million Equity Facility from Lincoln Park CSavant-7/22/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News